Genetic Polymorphisms in Monoamine Systems and Outcome of Cognitive Behavior Therapy for Social Anxiety Disorder
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The role of genetics for predicting the response to cognitive behavior therapy (CBT) for social anxiety disorder (SAD) has only been studied in one previous investigation. The serotonin transporter (5-HTTLPR), the catechol-o-methyltransferase (COMT) val158met, and the tryptophan hydroxylase-2 (TPH2) G-703T polymorphisms are implicated in the regulation of amygdala reactivity and fear extinction and therefore might be of relevance for CBT outcome. The aim of the present study was to investigate if these three gene variants predicted response to CBT in a large sample of SAD patients. METHOD: Participants were recruited from two separate randomized controlled CBT trials (trial 1: n = 112, trial 2: n = 202). Genotyping were performed on DNA extracted from blood or saliva samples. Effects were analyzed at follow-up (6 or 12 months after treatment) for both groups and for each group separately at post-treatment. The main outcome measure was the Liebowitz Social Anxiety Scale Self-Report. RESULTS: At long-term follow-up, there was no effect of any genotype, or gene × gene interactions, on treatment response. In the subsamples, there was time by genotype interaction effects indicating an influence of the TPH2 G-703T-polymorphism on CBT short-term response, however the direction of the effect was not consistent across trials. CONCLUSIONS: None of the three gene variants, 5-HTTLPR, COMTval158met and TPH2 G-703T, was associated with long-term response to CBT for SAD. TRIAL REGISTRATION: ClinicalTrials.gov (ID-NCT0056496).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“studies have been conducted on genetic variables, but findings have not been promising 83 .”
From Internet-delivered psychological treatments: from innovation to implementation (2019) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
(1998) · PubMed · Cited by 10,216
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“The s-allele of 5HTTLPR is associated with reduction of serotonin uptake and 5HTT expression [18].”
BackgroundMediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562 · cited 1×
“Therefore, there is a need to improve not only the treatments but also how patients are selected for treatment in order to optimize the efficacy [3,4].”
BackgroundSerotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Vulnerability genes or plasticity genes?
Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., & Williams, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.44 · Cited by 1,017 · cited 1×
“However, in a study on children with anxiety, ss homozygosity was associated with better outcome of CBT [5] suggesting that the s-allele might be a high-responsive allele rather than a specific risk-allele [26].”
BackgroundCatechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 685 · cited 1×
“The met (methionine)-allele is associated with lower enzyme activity, and reduces the effectiveness of dopamine degradation and thereby increases the synaptic availability of dopamine [27].”
BackgroundGenetics of emotional regulation: the role of the serotonin transporter in neural function
Hariri, A. R., & Holmes, A. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.02.011 · Cited by 669 · cited 1×
“The allele- or genotype frequencies did not deviate from previously reported distributions in general populations [12,44,45].”
ResultThe Liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis
Baker, S. L., Heinrichs, N., Kim, H.-J., & Hofmann, S. G. (2002) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(01)00060-2 · Cited by 640 · cited 6×
“In both trials, participants provided LSAS-SR data at pre and posttreatment and at follow-up.”
MethodInfluentialCognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
Clark, D. M., Ehlers, A., McManus, F., Hackmann, A., Fennell, M., Campbell, H., Flower, T., Davenport, C., & Louis, B. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.6.1058 · Cited by 561 · cited 1×
“As ICBT was designed as an individual treatment, the protocol was adapted from the individual CBT developed by Clark and colleagues [39]: the group protocol in trial 1 was based on the Heimberg [40] group therapy for SAD.”
MethodUsing the Internet to provide cognitive behaviour therapy
Andersson, G. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.01.010 · Cited by 560 · cited 1×
“Internet-delivered CBT is comprised of the same components as conventional CBT, but is delivered as an online bibliotherapy, with therapist contact through encrypted email [37].”
MethodSelf-citationCognitive behavioral group treatment for social phobia: Comparison with a credible placebo control
Heimberg, R. G., Dodge, C. S., Hope, D. A., Kennedy, C. R., Zollo, L. J., & Becker, R. E. (1990) · Cognitive Therapy and Research · doi:10.1007/bf01173521 · Cited by 500 · cited 1×
“As ICBT was designed as an individual treatment, the protocol was adapted from the individual CBT developed by Clark and colleagues [39]: the group protocol in trial 1 was based on the Heimberg [40] group therapy for SAD.”
MethodHow psychotherapy changes the brain – the contribution of functional neuroimaging
Linden, D. E. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001816 · Cited by 491 · cited 1×
“This is a crucial element of exposure-based therapy and is thought to be an active safety learning process leading to chemical and structural changes in the brain’s synaptic processes [11] which might be of relevance for the anxiolytic outcome of CBT.”
BackgroundCanli, T., Omura, K., Haas, B. W., Fallgatter, A., Constable, R. T., & Lesch, K. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503880102 · Cited by 359 · cited 1×
“Having the s-allele is associated with increased amygdala reactivity [10,19–21] and poorer treatment response to selective serotonin reuptake inhibitors (SSRIs) for social anxiety disorder (SAD) [22] and panic disorder [23].”
BackgroundBryant, R. A., Felmingham, K., Kemp, A., Das, P., Hughes, G., Peduto, A., & Williams, L. (2008) · Psychological Medicine · doi:10.1017/s0033291707002231 · Cited by 307 · cited 1×
“In patients with anxiety disorders, neural activity in the amygdala is reported to be predictive of both pharmacological [8] and psychosocial treatment outcomes including CBT [9,10].”
BackgroundHedman, E., Andersson, G., Ljótsson, B., Andersson, E., Rück, C., Mörtberg, E., & Lindefors, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018001 · Cited by 285 · cited 11×
“A detailed description of the original study is available elsewhere [34].”
BackgroundInfluentialSelf-citationGuided and unguided self-help for social anxiety disorder: randomised controlled trial
Furmark, T., Carlbring, P., Hedman, E., Sonnenstein, A., Clevberger, P., Bohman, B., Eriksson, A., Hållén, A., Frykman, M., Holmström, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.060996 · Cited by 256 · cited 1×
“Even though cognitive behavior therapy (CBT) is an effective treatment of anxiety disorders, many patients (25–50%) do not respond sufficiently [1,2].”
BackgroundSelf-citationLonsdorf, T. B., Weike, A. I., Nikamo, P., Schalling, M., Hamm, A. O., & Öhman, A. (2009) · Psychological Science · doi:10.1111/j.1467-9280.2009.02280.x · Cited by 241 · cited 1×
“Consistently, Lonsdorf and colleagues [30] also showed compromised fear extinction in metmet carriers.”
BackgroundSelf-citationA regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity
Brown, S. M., Peet, E., Manuck, S. B., Williamson, D. E., Dahl, R. E., Ferrell, R. E., & Hariri, A. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001716 · Cited by 241
Furmark, T., Tillfors, M., Garpenstrand, H., Marteinsdottir, I., Långström, B., Oreland, L., & Fredrikson, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.02.070 · Cited by 234 · cited 1×
“Having the s-allele is associated with increased amygdala reactivity [10,19–21] and poorer treatment response to selective serotonin reuptake inhibitors (SSRIs) for social anxiety disorder (SAD) [22] and panic disorder [23].”
BackgroundSelf-citationWhalen, P. J., Johnstone, T., Somerville, L. H., Nitschke, J. B., Polis, S., Alexander, A. L., Davidson, R. J., & Kalin, N. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.019 · Cited by 210 · cited 1×
“In patients with anxiety disorders, neural activity in the amygdala is reported to be predictive of both pharmacological [8] and psychosocial treatment outcomes including CBT [9,10].”
BackgroundFurmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-08.2008 · Cited by 210
Self-citationAmygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation
Canli, T., Congdon, E., Gutknecht, L., Constable, R. T., & Lesch, K. P. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0391-4 · Cited by 188 · cited 1×
“TPH2 holds a polymorphism, G-703T, in the promoter region where the T-variant of is associated with amygdala hyper responsivity both in healthy individuals [12,31] and in patients with SAD [10,32].”
BackgroundAndersson, G., Carlbring, P., Furmark, T., & on behalf of the S. O. F. I. E. Research Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0037411 · Cited by 166 · cited 3×
“The outcomes of the respective clinical trials are reported elsewhere [34,35].”
BackgroundMethodSelf-citationStein, M. B., Seedat, S., & Gelernter, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0349-8 · Cited by 161 · cited 1×
“Having the s-allele is associated with increased amygdala reactivity [10,19–21] and poorer treatment response to selective serotonin reuptake inhibitors (SSRIs) for social anxiety disorder (SAD) [22] and panic disorder [23].”
BackgroundTherapygenetics: the 5HTTLPR and response to psychological therapy
Eley, T. C., Hudson, J. L., Creswell, C., Tropeano, M., Lester, K. J., Cooper, P., Farmer, A., Lewis, C. M., Lyneham, H. J., Rapee, R. M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.132 · Cited by 145 · cited 3×
“The current results are not entirely consistent with some previous therapygenetic studies that have found association between 5-HTTLPR and response to CBT in a broader set of diagnoses after six months or longer post-treatment [5,14].”
BackgroundResultImaging genetics of anxiety disorders
Domschke, K., & Dannlowski, U. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.042 · Cited by 142
Bryant, R. A., Felmingham, K. L., Falconer, E. M., Benito, L. P., Dobson‐Stone, C., Pierce, K. D., & Schofield, P. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.016 · Cited by 132
Hedman, E., Andersson, E., Ljótsson, B., Andersson, G., Andersson, E., Schalling, M., Lindefors, N., & Rück, C. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01834.x · Cited by 114 · cited 4×
“Yet, a small-scale study of SAD found no effect of 5-HTTLPR on CBT outcome [3].”
BackgroundResultInfluentialSelf-citationPerna, G., Favaron, E., Bella, D. D., Bussi, R., & Bellodi, L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300822 · Cited by 102 · cited 1×
“Having the s-allele is associated with increased amygdala reactivity [10,19–21] and poorer treatment response to selective serotonin reuptake inhibitors (SSRIs) for social anxiety disorder (SAD) [22] and panic disorder [23].”
BackgroundEmpirical support for an involvement of the mesostriatal dopamine system in human fear extinction
Raczka, K. A., Mechias, M.-L., Gartmann, N., Reif, A., Deckert, J., Pessiglione, M., & Kalisch, R. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.10 · Cited by 101 · cited 1×
“treatment efficacy [5,13–15] and fear extinction processes [16,17] and might therefore influence the outcome of CBT.”
BackgroundLonsdorf, T. B., Rück, C., Bergström, J., Andersson, G., Öhman, A., Lindefors, N., & Schalling, M. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-99 · Cited by 88 · cited 2×
“In contrast to the study on panic disorder by Lonsdorf and colleagues [13], an effect of the COMTval158met polymorphism on CBT outcome could not be demonstrated.”
MethodResultSelf-citationÅberg, E., Losada, A. F., Sjöholm, L. K., Forsell, Y., & Lavebratt, C. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.009 · Cited by 83
Self-citationHuman fear reconsolidation and allelic differences in serotonergic and dopaminergic genes
Agren, T., Furmark, T., Eriksson, E., & Fredrikson, M. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.5 · Cited by 74 · cited 3×
“treatment efficacy [5,13–15] and fear extinction processes [16,17] and might therefore influence the outcome of CBT.”
BackgroundResultSelf-citationGenotype over diagnosis in amygdala responsiveness: affective processing in social anxiety disorder
Furmark, T., Henningsson, S., Appel, L., Åhs, F., Linnman, C., Pissiota, A., Faria, V., Oreland, L., Bani, M., Pich, E. M., et al. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0904 · Cited by 72
Self-citationLonsdorf, T. B., & Kalisch, R. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.36 · Cited by 69 · cited 1×
“This has in turn been suggested to affect fear extinction via fear memory consolidation [28].”
BackgroundNeurotrophic gene polymorphisms and response to psychological therapy
Lester, K. J., Hudson, J. L., Tropeano, M., Creswell, C., Collier, D. A., Farmer, A., Lyneham, H. J., Rapee, R. M., & Eley, T. C. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.33 · Cited by 62 · cited 2×
“The current results are not entirely consistent with some previous therapygenetic studies that have found association between 5-HTTLPR and response to CBT in a broader set of diagnoses after six months or longer post-treatment [5,14].”
ResultHermann, A., Küpper, Y., Schmitz, A., Walter, B., Vaitl, D., Hennig, J., Stark, R., & Tabbert, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044352 · Cited by 60 · cited 1×
“The TPH2 G-703T is also associated with fear conditioning processes [33].”
BackgroundRapid DNA purification for restriction fragment length polymorphism analysis
Lindblom, B., & Holmlund, G. (1988) · Gene Analysis Techniques · doi:10.1016/0735-0651(88)90003-9 · Cited by 58 · cited 1×
“DNA was extracted with standard methods from whole blood of 124 participants in trial 1 [43], and by Oragen Purifier from saliva of 202 participants in trial 2.”
MethodThe symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism
Lonsdorf, T. B., Rück, C., Bergström, J., Andersson, G., Öhman, A., Schalling, M., & Lindefors, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.004 · Cited by 56 · cited 1×
“These studies failed to demonstrate an effect of genotype immediate after treatment but at follow-up, whereas another study on panic patients, reported a significant effect of genotype both pre and post treatment [24].”
ResultSelf-citationTherapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy?
Bockting, C., Mocking, R. J. T., Lok, A., Koeter, M. W. J., & Schene, A. H. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.92 · Cited by 31 · cited 1×
“However, the expanding field of therapygenetics attempts to explore the relationship between genetic variation and psychological treatment response [5–7].”
BackgroundRotberg, B., Kronenberg, S., Carmel, M., Frisch, A., Brent, D. A., Zalsman, G., Apter, A., & Weizman, A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0020 · Cited by 26 · cited 1×
“In a recent study of pharmacological treatment of depression and anxiety among children and adolescents, the authors reported an additive effect of the 5HTTLPR s-allele and the TPH2 G-703T T-allele on poorer response to treatment [15].”
BackgroundSocial fobi - Effektiv hjälp med kognitiv beteendeterapi
Furmark, T., Holmström, A., Sparthan, E., Carlbring, P., & Andersson, G. (2006) · Cited by 12
Self-citation
Research works printed but not linked: 1
- KJ Lester, 2012, Neurotrophic gene polymorphisms and response to psychological therapy, Translational Psychiatry, 2, e108, 10.1038/tp.2012.33 · DOI · Paper page
Cited by
Internet-delivered psychological treatments: from innovation to implementation
Andersson, G., Titov, N., Dear, B. F., Rozental, A., & Carlbring, P. (2019) · World Psychiatry · doi:10.1002/wps.20610 · Cited by 750
Self-citationInternet-Delivered Psychological Treatments
Andersson, G. (2016) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093006 · Cited by 595
Self-citationAndersson, G., Carlbring, P., Titov, N., & Lindefors, N. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719839381 · Cited by 324
Self-citationInternet interventions: Past, present and future
Andersson, G. (2018) · Internet Interventions · doi:10.1016/j.invent.2018.03.008 · Cited by 315
Self-citationBakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2015) · Annual Review of Psychology · doi:10.1146/annurev-psych-010814-015407 · Cited by 266
Metadata
- Authors
- Andersson, E., Rück, C., Lavebratt, C., Hedman, E., Schalling, M., Lindefors, N., Eriksson, E., Carlbring, P., Andersson, G., & Furmark, T.
- Affiliations
- Karolinska Institutet (SE)
- University of Gothenburg (SE)
- Stockholm University (SE)
- Linköping University (SE)
- Uppsala University (SE)
- Corresponding author
- Rück, Christian
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-15
- Volume
- 8
- Issue
- 11
- Pages
- e79015
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3829855
- OpenAlex
- W2148020084
- Cited by
- 43
- References
- 46
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 10 · 2014: 1
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-10-18)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DiVA (Linkoping University) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Vetenskapsrådet
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- social anxiety disorder, cognitive behavioral therapy, treatment response prediction, genetic polymorphism, serotonin transporter, 5-HTTLPR, catechol-O-methyltransferase, COMT Val158Met, tryptophan hydroxylase 2, monoaminergic systems, gene-gene interaction, amygdala reactivity, fear extinction, Liebowitz Social Anxiety Scale
- MeSH terms
- Adolescent, Adult, Amygdala, Anxiety Disorders, Catechol O-Methyltransferase, Female, Follow-Up Studies, Genotype, Humans, Male, Middle Aged, Polymorphism, Genetic, Social Behavior Disorders, Tryptophan Hydroxylase, Cognitive Behavioral Therapy, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
